ExpreS2ion Biotech Holding AB (publ) 5JD.F Stock
ExpreS2ion Biotech Holding AB (publ) Price Chart
ExpreS2ion Biotech Holding AB (publ) 5JD.F Financial and Trading Overview
| ExpreS2ion Biotech Holding AB (publ) stock price | 0.16 EUR |
| Previous Close | 0.41 EUR |
| Open | 0.42 EUR |
| Bid | 0.38 EUR x N/A |
| Ask | 0.42 EUR x N/A |
| Day's Range | 0.42 - 0.42 EUR |
| 52 Week Range | 0.33 - 2.25 EUR |
| Volume | 100 EUR |
| Avg. Volume | 1 EUR |
| Market Cap | 17.59M EUR |
| Beta (5Y Monthly) | 1.267049 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.23 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
5JD.F Valuation Measures
| Enterprise Value | 15.42M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
ExpreS2ion Biotech Holding AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.267049 |
| 52-Week Change | -59.40% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.25 EUR |
| 52 Week Low | 0.33 EUR |
| 50-Day Moving Average | 0.41 EUR |
| 200-Day Moving Average | 0.93 EUR |
5JD.F Share Statistics
| Avg. Volume (3 month) | 1 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 39.94M |
| Float | 35.93M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 1.13% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 17.80% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -73.47% |
| Return on Equity (ttm) | -124.36% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | 24.60% |
| Gross Profit (ttm) | 1.07M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.26 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 2.52 EUR |
| Current Ratio (mrq) | 4.717 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of ExpreS2ion Biotech Holding AB (publ)
| Country | Germany |
| State | N/A |
| City | Horsholm |
| Address | SCION-DTU Science Park |
| ZIP | 2970 |
| Phone | 45 22 22 10 19 |
| Website | https://www.expres2ionbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase II clinical trial. It also develops influenza and breast cancer vaccine, which is in Phase II clinical trial, as well as develops malaria vaccine. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. ExpreS2ion Biotech Holding AB (publ) was founded in 2015 is based in Horsholm, Denmark.
Q&A For ExpreS2ion Biotech Holding AB (publ) Stock
What is a current 5JD.F stock price?
ExpreS2ion Biotech Holding AB (publ) 5JD.F stock price today per share is 0.16 EUR.
How to purchase ExpreS2ion Biotech Holding AB (publ) stock?
You can buy 5JD.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ExpreS2ion Biotech Holding AB (publ)?
The stock symbol or ticker of ExpreS2ion Biotech Holding AB (publ) is 5JD.F.
Which industry does the ExpreS2ion Biotech Holding AB (publ) company belong to?
The ExpreS2ion Biotech Holding AB (publ) industry is Biotechnology.
How many shares does ExpreS2ion Biotech Holding AB (publ) have in circulation?
The max supply of ExpreS2ion Biotech Holding AB (publ) shares is 59.85M.
What is ExpreS2ion Biotech Holding AB (publ) Price to Earnings Ratio (PE Ratio)?
ExpreS2ion Biotech Holding AB (publ) PE Ratio is now.
What was ExpreS2ion Biotech Holding AB (publ) earnings per share over the trailing 12 months (TTM)?
ExpreS2ion Biotech Holding AB (publ) EPS is -0.23 EUR over the trailing 12 months.
Which sector does the ExpreS2ion Biotech Holding AB (publ) company belong to?
The ExpreS2ion Biotech Holding AB (publ) sector is Healthcare.